The FDA granted the new indication for the serotonin 5-HT1A and dopamine D2 partial agonist a priority review earlier this year, and is due to deliver its decision by 10th May. The new application ...

The articles propose that increasing the availability of extrapyramidal serotonin levels could indirectly inhibit the release of dopamine in the striatum, increasing the stimulation of 5-HT1A ...

The search terms used for the PubMed database included 'aripiprazole', 'olanzapine', 'quetiapine', 'risperidone', 'ziprasidone', 'amisulpride', 'paliperidone ...

Among these are dopamine agonists and somatostatin analogs ... Cabergoline for Cushing's disease is typically initiated at 0.5 mg per week, with titration to a maximal dose of 7 mg/week.

Glucagon-like peptide-1 (GLP-1) receptor agonists have quickly become some of ... with an estimated 46.3 million Americans over age 12 meeting DSM-5 criteria for an SUD, with 29.5 million of ...

These receive incoming impulses from other neurones. Information from receptors passes along neurones, as electrical impulses to co-ordinators such as the central nervous system or CNS.

Images of crucial cell receptors show promising new drug targets Date: December 17, 2024 Source: University of Chicago Summary: New research combines two powerful imaging techniques to study the ...

Provided herein are novel ergoline compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating mood disorders such as depressive disorders and bipolar disorders, and ...